173 related articles for article (PubMed ID: 10454976)
1. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
[TBL] [Abstract][Full Text] [Related]
2. Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction.
Rosenschein U; Lenz R; Radnay J; Ben Tovim T; Rozenszajn LA
Isr J Med Sci; 1991 Oct; 27(10):541-5. PubMed ID: 1955306
[TBL] [Abstract][Full Text] [Related]
3. Streptokinase...never again.
van de Werf F
Eur Heart J; 1999 Sep; 20(17):1215. PubMed ID: 10454969
[No Abstract] [Full Text] [Related]
4. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
5. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
Kharash LM; Goldkhammer EI
Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
[TBL] [Abstract][Full Text] [Related]
6. [Repeat thrombolysis in acute myocardial infarction].
Király C; Timár S
Orv Hetil; 2001 Apr; 142(13):665-9. PubMed ID: 11338569
[TBL] [Abstract][Full Text] [Related]
7. The safety of automatic versus manual blood pressure cuffs for patients receiving thrombolytic therapy.
Saul L; Smith J; Mook W
Am J Crit Care; 1998 May; 7(3):192-6. PubMed ID: 9579244
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project.
Berger AK; Radford MJ; Krumholz HM
Am Heart J; 2000 Jun; 139(6):985-92. PubMed ID: 10827378
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
11. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
[TBL] [Abstract][Full Text] [Related]
12. Can anti-streptokinase antibody predict myocardial infarction outcomes after streptokinase treatment?
Sadeghi M; Golabchi A; Haghani P; Gharipour M; Naderi GA; Sarrafzadegan N
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S31-4. PubMed ID: 22768454
[TBL] [Abstract][Full Text] [Related]
13. Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction.
Juhlin P; Boström PA; Torp A; Bredberg A
J Intern Med; 1999 May; 245(5):483-8. PubMed ID: 10363749
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
Lee YY; Tee MH; Zurkurnai Y; Than W; Sapawi M; Suhairi I
Singapore Med J; 2008 Apr; 49(4):304-10. PubMed ID: 18418522
[TBL] [Abstract][Full Text] [Related]
16. T-ceIl recognition of discrete regions of the thrombolytic drug streptokinase.
Lawley WJ; Fletcher S; Squire IB; Woods KL; Hewitt CR
Clin Sci (Lond); 2000 Sep; 99(3):239-46. PubMed ID: 11787478
[TBL] [Abstract][Full Text] [Related]
17. [Anaphylactic reaction in streptokinase therapy].
Hohage H; Schulte B; Pfeiff B; Pullmann H
Wien Klin Wochenschr; 1993; 105(6):176-8. PubMed ID: 8475630
[TBL] [Abstract][Full Text] [Related]
18. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
[TBL] [Abstract][Full Text] [Related]
20. Eligibility of patients with acute myocardial infarction for thrombolytic therapy: retrospective cohort study.
Zaputović L; Mavrić Z; Mlinarić B; Kupanovac Z; Matana A; Marinović D
Croat Med J; 2000 Dec; 41(4):401-5. PubMed ID: 11063763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
